Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
55.60
-0.30 (-0.54%)
Jul 3, 2025, 1:30 PM CST
9.45%
Market Cap 4.85B
Revenue (ttm) 4.44B
Net Income (ttm) -347.80M
Shares Out 86.75M
EPS (ttm) -4.01
PE Ratio n/a
Forward PE n/a
Dividend 1.00 (1.78%)
Ex-Dividend Date Jul 7, 2025
Volume 148,089
Average Volume 318,630
Open 55.90
Previous Close 55.90
Day's Range 55.20 - 55.90
52-Week Range 40.05 - 60.70
Beta 0.24
RSI 65.98
Earnings Date Aug 11, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.